Scott leverages his technical experience as a member of research teams at Genentech (Virology R&D) and the NASA Ames Research Center (Advanced Displays Lab) to provide a unique business and legal perspective to companies commercializing disruptive solutions in technology and healthcare. In recognition for such work, The Recorder named Scott one of its “Lawyers on the Fast Track.”
Scott has represented a majority of such companies from inception, with many of the companies founded by leading entrepreneurs and scientists at University of California, Stanford University and Harvard University. He also works with non-profit entities, including the Ronald McDonald House Charities of the Bay Area. Scott’s practice has included representation of numerous high growth companies, including:
Technology
Facebook
Instagram
Nervana Systems
Planet Labs
ResearchGate
Life Science/Healthcare
Cortexyme
CyberHeart
EpiBone
GRO Bioscience
Virta Health
Stemming from his experience and deep knowledge in the life sciences and technology industries, Scott is a frequently sought after advisor, speaker and author on technology companies. He routinely volunteers his time with entrepreneur groups and frequently lectures at forums such as the National Cancer Institute, Stanford School of Medicine, Stanford University, Stanford Technology Venture Program, the University of California, Los Angeles and the California Life Sciences Association.
Johann advises startups and tech companies as well as VC funds in on their fundraising, external growth operations, and exits. He has been involved in more than 40 transactions with companies such as Mistral AI, Alan, BeReal, amo, Dust or Nabla, or investors such as Cathay Innovation, Highland Europe, RA Capital Management and Sequoia Capital.
Throughout the growth lifecycle of startups, Johann assists management teams in setting up employee incentive plans and providing practical advice on corporate governance.
As a dual-qualified lawyer admitted to the Paris and New-York bars, Johann supports companies in their cross-border operations and their establishment in the United States.
Prior to joining Orrick, Johann was an associate in the Paris office of an American law firm.
Dan has experience across the full spectrum and life cycle of financial services firms: from determining whether the firm's products or services are the subject of financial services regulation, assistance in obtaining a regulatory license, interpretation of applicable regulations and implementation guidance through to M&A regulatory due diligence and skilled person's reports in the event of regulatory investigation.
His clients include global retail and investment banks, asset managers, e-money issuers and payments services providers, crypto-asset issuers, wallets and exchanges.
Dan's notable work includes advice to the UK Open Banking implementation body, the development of a digital only retail bank for a U.S. headquartered global bank and preparing the regulatory license application for a leading global payment services provider.
Before joining Orrick, Dan spent more than a decade working in UK ‘magic circle’ law and ‘Big 4’ consulting firms, advising leading fintech's on regulatory issues across the UK, Europe and the Middle East.
Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.
Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.
In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.
A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.
Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”
Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.
These matters involved issues such as government contractor immunity to patent infringement; the effect of amendments to a patent licensing agreement; the effect of an expired utility patent for a chemical composition on the validity of a related trademark for medical implants; the copyrightability of short phrases and the merger doctrine; the copyrightability and fair use of religious materials; and multiple oppositions to office actions, and petitions to cancel trademark registrations to the Trademark Trial & Appeal Board.
Daniel has also worked on Internet-related matters involving the legal effect of “browsewrap” agreements; violations of Web page terms of use; the circumvention of technological barriers to access Web pages; violations of the Computer Fraud and Abuse Act; copyright issues related to cache copying of Web pages; the use of “spiders” to collect data from Web pages; the legality of “deep-linking” to web pages; and the legality of search engine aggregation and display of copyrighted Web pages.
Daniel has recently co-authored a scholarly article with Warrington S. Parker III entitled, "The Differing Approaches to Preemption Under the Uniform Trade Secrets Act" that was published in Volume 49, Issue 2 of the Tort Trial & Insurance Practice Law Journal. Daniel is also a contributing author to the NorCal IP Blog, which covers notable new intellectual property case filings and verdicts in the Northern District of California. Links to articles Daniel has authored can be found under the "Publications" section of this bio.
Jamie's practice focuses on domestic and cross-border mergers and acquisitions, advising companies on formation and equity financings, and corporate governance matters.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.